v3.26.3
CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2026
Jun. 30, 2025
CURRENT ASSETS    
Cash and cash equivalents $ 1,569,453 $ 55,639
Crypto assets 5,078,444  
Other receivables, net 543,981 1,035,865
Prepayments, net 351,769 554,995
Loans receivable, net 2,624,401 1,889,941
Total current assets 10,168,048 3,536,440
NONCURRENT ASSETS    
Loans receivable, net 10,791,469  
Deposit for long-term investment 200,000  
Total noncurrent assets 10,991,469  
Total assets 21,159,517 3,536,440
CURRENT LIABILITIES    
Other payables and accrued liabilities 1,457,088 372,083
Total current liabilities 1,457,088 372,083
NONCURRENT LIABILITIES    
Convertible debentures 10,624,818  
Total noncurrent liabilities 10,624,818  
Total liabilities 12,081,906 372,083
COMMITMENTS AND CONTINGENCIES (Note 13)
Class A Ordinary Shares subject to potential redemption, 66,668 and nil shares issued and outstanding as of June 30, 2026 and 2025, respectively [1] 4,201,307  
SHAREHOLDERS' EQUITY    
Additional paid-in capital 117,330,148 92,165,483
Accumulated deficit (112,190,583) (88,265,410)
Other comprehensive income 480,001  
Total SANGRIX INC. shareholders' equity 5,619,790 3,900,132
NONCONTROLLING INTERESTS (743,486) (735,775)
Total shareholders' equity [1] 4,876,304 3,164,357
Total liabilities, mezzanine equity and shareholders' equity 21,159,517 3,536,440
Class A Ordinary Shares    
SHAREHOLDERS' EQUITY    
Ordinary Share [1] 219 58
Class B Ordinary Shares    
SHAREHOLDERS' EQUITY    
Ordinary Share [1] $ 5 $ 1
[1] Giving retroactive effect to the 1-for-60 reverse share split effected on January 20, 2026 and the 1-for-5 reverse share split effected on August 21, 2026